Cargando…
Novel g-C(3)N(4)/PrFeO(3) nanocomposites with Z-scheme structure and superior photocatalytic activity toward visible-light-driven removal of tetracycline antibiotics
In the presented work, heterostructured nanocomposites based on g-C(3)N(4) and PrFeO(3) with different mass content of PrFeO(3) (0–10 wt%) were prepared by ultrasonic processing to study their photocatalytic activity in the process of antibiotic degradation under visible light. The study of phase co...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10682019/ https://www.ncbi.nlm.nih.gov/pubmed/38034765 http://dx.doi.org/10.1016/j.heliyon.2023.e22038 |
_version_ | 1785150886823067648 |
---|---|
author | Chebanenko, M.I. Lebedev, L.A. Seroglazova, A.S. Lobinsky, A.A. Gerasimov, E.Y. Stovpiaga, E. Yu Popkov, V.I. |
author_facet | Chebanenko, M.I. Lebedev, L.A. Seroglazova, A.S. Lobinsky, A.A. Gerasimov, E.Y. Stovpiaga, E. Yu Popkov, V.I. |
author_sort | Chebanenko, M.I. |
collection | PubMed |
description | In the presented work, heterostructured nanocomposites based on g-C(3)N(4) and PrFeO(3) with different mass content of PrFeO(3) (0–10 wt%) were prepared by ultrasonic processing to study their photocatalytic activity in the process of antibiotic degradation under visible light. The study of phase composition, structural, morphological and textural characteristics carried out by powder X-ray diffraction, scanning electron microscopy and adsorption-structural analysis confirmed the presence of two phases - graphite-like C(3)N(4) and orthorhombic PrFeO(3) with average crystallite sizes of 5 and 21 nm and mesoporous structure with specific surface area of 57.2–68.6 m(2)/g and average pore size of 20 nm. The measured values of the forbidden bandwidth for the obtained nanocomposites were ∼3 eV, indicating potential activity under visible light irradiation. The efficiency of antibiotic removal under visible light was evaluated in the degradation of TCHCl. It was found that 5 % PrFeO(3) content was optimal and increased the TOF by 5 times compared to pure g-C(3)N(4). The results of photocatalytic test with absorbers showed that photocatalysis occurs by Z-scheme mechanism. The results obtained allow us to consider this nanocomposite as an effective and stable photocatalyst for pharmaceutical wastewater treatment. |
format | Online Article Text |
id | pubmed-10682019 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-106820192023-11-30 Novel g-C(3)N(4)/PrFeO(3) nanocomposites with Z-scheme structure and superior photocatalytic activity toward visible-light-driven removal of tetracycline antibiotics Chebanenko, M.I. Lebedev, L.A. Seroglazova, A.S. Lobinsky, A.A. Gerasimov, E.Y. Stovpiaga, E. Yu Popkov, V.I. Heliyon Research Article In the presented work, heterostructured nanocomposites based on g-C(3)N(4) and PrFeO(3) with different mass content of PrFeO(3) (0–10 wt%) were prepared by ultrasonic processing to study their photocatalytic activity in the process of antibiotic degradation under visible light. The study of phase composition, structural, morphological and textural characteristics carried out by powder X-ray diffraction, scanning electron microscopy and adsorption-structural analysis confirmed the presence of two phases - graphite-like C(3)N(4) and orthorhombic PrFeO(3) with average crystallite sizes of 5 and 21 nm and mesoporous structure with specific surface area of 57.2–68.6 m(2)/g and average pore size of 20 nm. The measured values of the forbidden bandwidth for the obtained nanocomposites were ∼3 eV, indicating potential activity under visible light irradiation. The efficiency of antibiotic removal under visible light was evaluated in the degradation of TCHCl. It was found that 5 % PrFeO(3) content was optimal and increased the TOF by 5 times compared to pure g-C(3)N(4). The results of photocatalytic test with absorbers showed that photocatalysis occurs by Z-scheme mechanism. The results obtained allow us to consider this nanocomposite as an effective and stable photocatalyst for pharmaceutical wastewater treatment. Elsevier 2023-11-07 /pmc/articles/PMC10682019/ /pubmed/38034765 http://dx.doi.org/10.1016/j.heliyon.2023.e22038 Text en © 2023 The Authors. Published by Elsevier Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Research Article Chebanenko, M.I. Lebedev, L.A. Seroglazova, A.S. Lobinsky, A.A. Gerasimov, E.Y. Stovpiaga, E. Yu Popkov, V.I. Novel g-C(3)N(4)/PrFeO(3) nanocomposites with Z-scheme structure and superior photocatalytic activity toward visible-light-driven removal of tetracycline antibiotics |
title | Novel g-C(3)N(4)/PrFeO(3) nanocomposites with Z-scheme structure and superior photocatalytic activity toward visible-light-driven removal of tetracycline antibiotics |
title_full | Novel g-C(3)N(4)/PrFeO(3) nanocomposites with Z-scheme structure and superior photocatalytic activity toward visible-light-driven removal of tetracycline antibiotics |
title_fullStr | Novel g-C(3)N(4)/PrFeO(3) nanocomposites with Z-scheme structure and superior photocatalytic activity toward visible-light-driven removal of tetracycline antibiotics |
title_full_unstemmed | Novel g-C(3)N(4)/PrFeO(3) nanocomposites with Z-scheme structure and superior photocatalytic activity toward visible-light-driven removal of tetracycline antibiotics |
title_short | Novel g-C(3)N(4)/PrFeO(3) nanocomposites with Z-scheme structure and superior photocatalytic activity toward visible-light-driven removal of tetracycline antibiotics |
title_sort | novel g-c(3)n(4)/prfeo(3) nanocomposites with z-scheme structure and superior photocatalytic activity toward visible-light-driven removal of tetracycline antibiotics |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10682019/ https://www.ncbi.nlm.nih.gov/pubmed/38034765 http://dx.doi.org/10.1016/j.heliyon.2023.e22038 |
work_keys_str_mv | AT chebanenkomi novelgc3n4prfeo3nanocompositeswithzschemestructureandsuperiorphotocatalyticactivitytowardvisiblelightdrivenremovaloftetracyclineantibiotics AT lebedevla novelgc3n4prfeo3nanocompositeswithzschemestructureandsuperiorphotocatalyticactivitytowardvisiblelightdrivenremovaloftetracyclineantibiotics AT seroglazovaas novelgc3n4prfeo3nanocompositeswithzschemestructureandsuperiorphotocatalyticactivitytowardvisiblelightdrivenremovaloftetracyclineantibiotics AT lobinskyaa novelgc3n4prfeo3nanocompositeswithzschemestructureandsuperiorphotocatalyticactivitytowardvisiblelightdrivenremovaloftetracyclineantibiotics AT gerasimovey novelgc3n4prfeo3nanocompositeswithzschemestructureandsuperiorphotocatalyticactivitytowardvisiblelightdrivenremovaloftetracyclineantibiotics AT stovpiagaeyu novelgc3n4prfeo3nanocompositeswithzschemestructureandsuperiorphotocatalyticactivitytowardvisiblelightdrivenremovaloftetracyclineantibiotics AT popkovvi novelgc3n4prfeo3nanocompositeswithzschemestructureandsuperiorphotocatalyticactivitytowardvisiblelightdrivenremovaloftetracyclineantibiotics |